Origene | GenomeWeb

Origene

OriGene Technologies said this week that it has acquired Foster City, Calif.-based immunoassay firm BioCheck.

NEW YORK (GenomeWeb News) – OriGene Technologies announced that it has received a contract from the National Cancer Institute to develop high affinity anti-peptide antibodies for SISCAPA assays.

NEW YORK (GenomeWeb News) – OriGene Technologies and SDIX today announced a definitive agreement for OriGene to buy the Life Science assets of SDIX for $16 million.

NEW YORK (GenomeWeb News) – OriGene Technologies today announced the completion of its $21.3 million Series C financing round.
Qiming Venture Partners and Kleiner Perkins Caufield Byers China led the round, while existing investor IDG-Accel also participated, OriGene said.

Canada's Centre of Excellence for the Prevention of Organ Failure – also called the PROOF Centre – has partnered with Origene Technologies on blood-based protein assays for monitoring heart and kidney transplantation.

Proteome Sciences this week introduced its SysQuant Assay, a multiplexed mass spec-based assay for quantification of phosphoproteins.

New Product Watch

Premium

Affymetrix this week launched its Human Transcriptome Array.

New Product Watch

Premium

BlueGnome's CytoChip SNP 4x180K and CytoChip Cancer SNP 4x180K Microarrays, Origene Technologies' TrueMab Antibody Portfolio

New Products

Premium

Origene

New Products

Premium

Agilent, Thermo Fisher Scientific, Waters, NextGen Sciences, Protea Biosciences, Origene

Pages

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.